{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["177"],"submitter":["Silecchia G"],"funding":["Ethicon Endo-Surgery Inc","Johnson and Johnson"],"pubmed_abstract":["<h4>Background</h4>Sars-Cov-2 epidemic in Italy caused one of the greatest 2020 European outbreaks, with suspension of elective bariatric/metabolic surgery (BMS). From May 2020 a significant decline of the epidemic has been observed (phase 2); National Health Service protocols permitted elective BMS' resumption. A new, more severe COVID-19 surge, the \"second wave\", started on October 2020 (phase 3).<h4>Aim</h4>The primary end point was to analyze the outcomes of any Sars-Cov-2 infection and related morbidity/mortality within 30 POD after laparoscopic BMS during phase 2-3; secondary end points were readmission and reoperation rates.<h4>Methods</h4>Study design prospective, multicenter, observational.<h4>Setting</h4>Eight Italian high-volume bariatric centers. All patients undergoing BMS fro"],"journal":["Diabetes research and clinical practice"],"pagination":["108919"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8200253"],"repository":["biostudies-literature"],"pubmed_title":["Laparoscopic bariatric surgery is safe during phase 2-3 of COVID-19 pandemic in Italy: A multicenter, prospective, observational study."],"pmcid":["PMC8200253"],"pubmed_authors":["Bernante P","Silecchia G","Anselmino M","Bianciardi E","Campanelli M","M Marinari G","Fiorello L","Mancini R","Boru CE","Tascini C","Morino M","Foletto M","Trotta M","Oldani A","Salzano A","Rottoli M","cooperative RESTART group","Morganti R","Gentileschi P","Olmi S"],"additional_accession":[]},"is_claimable":false,"name":"Laparoscopic bariatric surgery is safe during phase 2-3 of COVID-19 pandemic in Italy: A multicenter, prospective, observational study.","description":"<h4>Background</h4>Sars-Cov-2 epidemic in Italy caused one of the greatest 2020 European outbreaks, with suspension of elective bariatric/metabolic surgery (BMS). From May 2020 a significant decline of the epidemic has been observed (phase 2); National Health Service protocols permitted elective BMS' resumption. A new, more severe COVID-19 surge, the \"second wave\", started on October 2020 (phase 3).<h4>Aim</h4>The primary end point was to analyze the outcomes of any Sars-Cov-2 infection and related morbidity/mortality within 30 POD after laparoscopic BMS during phase 2-3; secondary end points were readmission and reoperation rates.<h4>Methods</h4>Study design prospective, multicenter, observational.<h4>Setting</h4>Eight Italian high-volume bariatric centers. All patients undergoing BMS fro","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jul","modification":"2025-04-04T10:49:32.195Z","creation":"2022-02-11T02:16:38.09Z"},"accession":"S-EPMC8200253","cross_references":{"pubmed":["34133962"],"doi":["10.1016/j.diabres.2021.108919"]}}